AITX Announces Q1 FY 2025 Recurring Monthly Revenue Increase of 385% YoY, Announces First Ever Quarter of Over $1 Million in Total Revenue
June 17, 2024 08:40 ET
|
Artificial Intelligence Technology Solutions, Inc.
Company Also Announces RMR Waiting Deployment of Over $125,000 Detroit, Michigan, June 17, 2024 (GLOBE NEWSWIRE) -- Artificial Intelligence Technology Solutions, Inc., (the “Company”) (OTCPK:AITX),...
Longeveron Announces Exercise of Warrants for $4.4 Million Gross Proceeds
June 17, 2024 08:38 ET
|
Longeveron
Longeveron Announces Exercise of Warrants for $4.4 Million Gross Proceeds
Triumph Financial and C.H. Robinson Announce Strategic Relationship
June 17, 2024 08:35 ET
|
Triumph Financial, Inc.
Triumph Financial and C.H. Robinson announced today a strategic relationship focused on delivering innovative payment solutions.
Rothamsted Research Grants Yield10 Bioscience an Exclusive, Global Commercial License to Advanced Technology for Producing Omega-3 Products in Camelina
June 17, 2024 08:32 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass. and HARPENDEN, United Kingdom, June 17, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (OTC:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced...
Aerovate Therapeutics Announces 24-Week Topline Results from the Phase 2b Portion of IMPAHCT Evaluating AV-101 for the Treatment of Pulmonary Arterial Hypertension
June 17, 2024 08:32 ET
|
Aerovate Therapeutics, Inc.
WALTHAM, Mass., June 17, 2024 (GLOBE NEWSWIRE) -- Aerovate Therapeutics, Inc. (Nasdaq: AVTE) today announced topline results from the Phase 2b portion of the Inhaled iMatinib Pulmonary Arterial...
P10 Announces Results of its Annual Meeting of Stockholders
June 17, 2024 08:30 ET
|
P10, Inc.
DALLAS, June 17, 2024 (GLOBE NEWSWIRE) -- P10, Inc. (NYSE: PX) (the “Company”), a leading private markets solutions provider, announced the voting results of its Annual Meeting of Stockholders. All...
Mustang Bio Announces Favorable Efficacy and Safety Data from Complete Waldenstrom Macroglobulinemia Cohort of Phase 1/2 Clinical Trial of MB-106, CD20-Targeted Autologous CAR-T Therapy
June 17, 2024 08:30 ET
|
Mustang Bio, Inc.
Overall response rate of 90% in cohort with durable responses observed; one patient remains in complete remission at 31 months All patients were heavily pretreated/refractory to BTK inhibitors, and...
Orrstown Financial Services, Inc. and Codorus Valley Bancorp, Inc. Announce Receipt of Regulatory Approvals for Merger of Equals
June 17, 2024 08:30 ET
|
Orrstown Financial Services, Inc.; Codorus Valley Bancorp, Inc.
SHIPPENSBURG, Pa. and YORK, Pa., June 17, 2024 (GLOBE NEWSWIRE) -- Orrstown Financial Services, Inc. (“Orrstown”) (NASDAQ: ORRF), the parent company of Orrstown Bank, and Codorus Valley Bancorp,...
Evoke Pharma Reports Commercial Strategy Progress & Positive Momentum for GIMOTI
June 17, 2024 08:30 ET
|
Evoke Pharma, Inc.
Expanded State Medicaid Access for GIMOTI Achieved highest ever monthly GIMOTI prescription fills in May 2024 Promoted former VP of Finance, Mark Kowieski to Chief Financial Officer SOLANA...
Butler Hall Capital LLC has issued an open letter to VNDA’s board of directors urging the company to run a full sales process to maximize shareholder value
June 17, 2024 08:30 ET
|
Butler Hall Capital, LLC
Butler Hall urges Vanda’s Board to adhere to its fiduciary duty to shareholders and run a full sales process following three new unsolicited offers for the Company Butler Hall believes a sales...